HAVCR2 and COVID-19: The decrease and functional depletion in T cells in patients with COVID-19 is associated with mortality and increased expression of immune-inhibiting factors, such as programmed death-1 (PD-1) and T cell immunoglobulin mucin-3 (TIM-3), which are usually observed in patients progressing from prodromal to clearly symptomatic stages.